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Adaptor proteins play an important role in signaling pathways by providing a platform on which
many other proteins can interact. Malfunction or mislocalization of these proteins may play a role
in the development of disease. Lipoma preferred partner (LPP) is a nucleocytoplasmic shuttling
adaptor protein. Previous work shows that LPP plays a role in the function of smooth muscle cells
and in atherosclerosis. In this study we wanted to determine whether LPP has a role in the myocar-
dium. LPP expression increased by 56% in hearts from pressure overload aortic-banded rats (p < 0.05
n = 4), but not after myocardial infarction, suggesting hemodynamic load regulates its expression. In
vitro, LPP expression was 87% higher in cardiac ﬁbroblasts than myocytes (p < 0.05 n = 3). LPP
expression was downregulated in the absence of the actin cytoskeleton but not when microtubules
were disassembled. We mechanically stretched cardiac ﬁbroblasts using the Flexcell 4000 for 48 h
(1 Hz, 5% maximum strain), which decreased total LPP total expression and membrane localization
in subcellular fractions (p < 0.05, n = 5). However, L-NAME, an inhibitor of nitric oxide synthase
(NOS), signiﬁcantly upregulated LPP expression. These ﬁndings suggest that LPP is regulated by a
complex interplay between NO and mechanical cues and may play a role in heart failure induced
by increased hemodynamic load.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
Adaptor proteins play an important role in many biological sig-
naling pathways by providing a platform on which many other
proteins can interact [1]. The interaction of these adaptor proteins
mean that they can regulate both the site and duration of many
important signaling pathways required for normal cell function.
Equally, malfunction or mislocalization of these proteins may play
a role in the development of human disease. Lipoma preferred
partner (LPP) contains three LIM domains and is from a family of
adaptor proteins that include thyroid hormone receptor interact-
ing protein 6 (TRIP6) and Zyxin [2]. One of the difﬁculties in deter-
mining the cellular function of LPP results from the fact that there
is some functional redundancy with other members of the zyxin
family [3]. LPP is a nucleocytoplasmic shuttling protein located in
the focal adhesions and cell–cell junctions and associates with
the actin cytoskeleton [4]. The proline-rich domain of LPP enables
it to form links with cytoskeletal components such as actin stress
ﬁbers and a-actinin [5]. At the focal adhesions LPP binds to theal Societies. Published by Elsevier
ical Sciences and Pharmacy,
hts, Reading, Berkshire RG6
eng).ends of actin ﬁlaments to prompt cell attachment. LPP contributes
a regulatory step by controlling the rate of actin polymerization,
where its LIM domains act in an inhibitory manner to impede for-
mation of the links [6]. Such functions suggest that whilst concen-
trated at the focal adhesion, LPP contributes to the force exerted by
the cell onto the extracellular space [7].
Mutations in the LPP gene have been associated with a group of
tumors of adipose tissue [8]. These mutations result in the perma-
nent localization of the LIM domains to the nucleus. The protein
has been shown to be a nuclear-cytoplasmic shuttling protein
since inhibition of the nuclear export factor CRM1 with leptomycin
B causes LPP to accumulate in the nucleus [4].
LPP has been described as an oncogene in various cells [9] and
has been shown to play an important role in the function of
smooth muscle cells [10]. Previous work has also shown LPP to
play an important role in the development of atherosclerosis in
coronary vessels due to its mechanosensitivity [11]. Its activity in
the heart has not been studied before because previous work had
suggested that LPP was not expressed there [12].
In this paper we present evidence to show for the ﬁrst time that
LPP is highly expressed within the myocardium and is up regulated
following heart failure induced by pressure overload but not myo-
cardial infarction. These ﬁndings suggest that LPP may be a novel
marker for hemodynamic load-induced adaptation in the heartB.V. Open access under CC BY-NC-ND license.
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overload. Moreover, we demonstrate that LPP is a mechanosensi-
tive protein in cardiac ﬁbroblasts where its expression is highest.
The mechano-regulation of LPP expression is nitric oxide depen-
dent. These data suggest that LPP is a novel mechanosensing
protein in the heart regulating cell adaptation in cardiac hypertro-
phy and heart failure through nitric oxide signaling.2. Materials and methods
2.1. Animals models of heart failure
Animal experiments were performed according to Institutional
Animal Care of the University of Illinois at Chicago (UIC) and Use
Committee and NIH guidelines. For the transverse aortic banding
procedure, rats were initially anesthetized with methoxyﬂuorane
and suture placed on ascending aorta to induce cardiac hypertro-
phy as previously described [13]. For myocardial infarction the left
coronary artery was ligated 5 mm from the ostium with 7-0 silk
suture as previously described [13]. For controls, animals were
sham operated without the constriction or coronary ligation. In
each case, animals were killed with end-stage heart failure 6–
7 months post-surgery with carbon dioxide, and heart tissue was
stored at 80 C prior to use. In the myocardial infarcted hearts,
tissue was collected from the remote region in an area away from
the infarct. All surgery, hemodynamics and tissue dissections were
performed at UIC and shipped to Reading on dry ice. Subsequent
experiments were performed at the University of Reading.
2.2. Cell culture and treatments
Myocytes and ﬁbroblasts were isolated from the cardiac ven-
tricles of 1–2 day old Sprague–Dawley rats by sequential collage-
nase digestion, as previously described [14]. Myocytes were
cultured PC1 medium (BioWhittaker, Walkersville, MD) for 24 h
and transferred to a DMEM:M199 serum free medium. Cardiac
ﬁbroblasts were cultured in 5% serum in DMEM. Cardiac ﬁbro-
blasts were cyclically stretched at 1 Hz using the Flexcell 4000
(Flexcell International). For short term experiments, cells were
stretched at 10% maximum strain for 2 h. However for long term
experiments, the cells were stretched at 5% maximum strain for
48 h to prevent signiﬁcant cell detachment. This reduced inten-
sity still had effects on the ﬁbroblasts as shown by increased
cross linking of actin cytoskeleton. Cells were changed to serum
free medium overnight and treated with drugs prior to the cells
being stretched and during stretch. Fibroblasts were treated with
10 lM vinblastine for 26 h (to dissociate microtubules) or 5 mM
LNAME for 48 h (to inhibit NOS and prevent NO production). Cells
were treated with cytochalasin D at 10 lM for 26 h (to dissociate
polymerized actin) when combined with 2 h 10% stretch or 72 h
when combined with 48 h 5% stretch. Leptomycin was used at
10 nM for 2 h to inhibit CRM1 dependent nuclear export. These
drug concentrations have been shown to be speciﬁc for their
respective targets.
2.3. Cellular composition and subcellular fractionation
For subcellular fractionation of myocytes, the ProteoExtract
Subcellular Proteome Kit from Calbiochem was used as described
previously [14]. Cellular proteins were sequentially extracted into
four compartments: cytosolic, membrane/organelles, nuclei and
cytoskeleton. The accuracy of the fractionation method was veri-
ﬁed with antibodies to well documented subcellular markers (data
not shown). However, we have previously documented the accu-
racy of this methodology [13].2.4. Western blotting for analysis of protein expression
Neonatal rat ventricular myocytes were rinsed with warm PBS
and then scraped from the silicone membranes or dishes in lysis
buffer containing 1% SDS and protease inhibitor cocktail (Sigma).
For whole heart protein analysis, tissue was ground in liquid nitro-
gen and added to lysis buffer containing 1% SDS, 50 mM NaF and
protease inhibitor cocktail (Sigma). Protein samples were analyzed
byWestern blotting as described previously [14]. Gels were probed
for LPP 1 in 2000 (Abcam), actin 1 in 1000 (Abcam), procollagen 1
in 200 (Developmental Studies Hybridoma Bank), a-smooth
muscle actin 1 in 1000 (Abcam) and vimentin 1 in 1000 (Abcam).
Gels were analyzed and quantiﬁed using the total protein
loading from the Amido black stain as previously described [15].
The gels were scanned and analyzed using Gel Pro Analyser
(mediacybernetics).
2.5. Immuno-chemistry and image analysis
After the various experimental protocols, cells for immuno-
cytochemical staining were ﬁxed in 4% paraformaldehyde for
5 min and then 70% ethanol for storage at 20 C. Cells were
rehydrated in PBS and then immunostained with antibodies as de-
scribed previously [16]. Cells were stained for LPP, actin, procolla-
gen, a-smooth muscle actin, tubulin and integrin-linked kinase. All
primary antibodies were used at a concentration of 1 in 500 over-
night. Alexa Fluor-conjugated secondary antibodies (Molecular
Probes) were used to visualize the speciﬁc proteins using a Leica
DMIRE2 laser scanning confocal microscope.
2.6. Statistics
For the experiments described here, at least three separate pri-
mary cultures were averaged. Each culture used about 30 neonatal
hearts. All values are means ± SEM. For the animal experiments
each group had between 4 and 8 animals. All values of signiﬁcance
were calculated using the appropriate comparisons: one way anal-
ysis of variance or the Students unpaired t-test. Differences among
means were considered signiﬁcant at p < 0.05. Data were analyzed
using GraphPad, Minitab and SigmaStat statistical software.3. Results
3.1. LPP distribution in normal and failing hearts
Previous work has suggested that the heart expresses very low
levels of LPP compared with other tissue so we determined the
expression of the protein in rat heart samples taken from adult at-
rium, left and right ventricles and from the neonatal ventricles. We
compared the expression of LPP with another focal adhesion pro-
tein paxillin. Fig. 1a shows a Western blot of LPP from heart tissue
from rat and shows that the protein was expressed in all tissues
examined. Fig. 1B shows quantitation of LPP and shows that the
protein is expressed in all regions of the adult heart with the atria
having a two-fold higher expression of LPP compared with the
ventricles, (atrium vs ventricles p < 0.05). The expression of LPP
in neonatal ventricles was also higher compared with the adult,
(neonatal heart vs adult heart, p < 0.01).
With high expression of LPP in neonatal hearts, we wondered
whether the expression of the protein might be altered in the fail-
ing heart. We determined the expression of LPP protein in two
models of heart failure, pressure overload by ascending aortic con-
striction (AOB) and myocardial infarction (MI) by coronary ligation.
We chose these two models because our previous work has shown
a signiﬁcant difference in hemodynamics between the two models
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Fig. 1. (A) Western blots of LPP and paxillin protein in the adult rat left and right ventricle, adult atria and neonatal ventricle. (B) LPP protein expression in the adult rat left
and right ventricle, adult atria and neonatal ventricle. LPP protein expression was three-fold higher in the neonatal ventricles than in the adult. p < 0.05, n = 3 (C) Western
blots of LPP and actin protein in the left ventricular free wall of aortic banded hearts. (D) LPP protein expression is higher after aortic banding than in control hearts. p < 0.05,
n = 4. (E) Actin protein expression was unchanged in the aortic banded hearts compared to controls. (F) Western blots of LPP and actin protein in the left ventricular free wall
after myocardial infarction. (G) LPP protein expression was unchanged after myocardial infarction.
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Fig. 2. Immunostaining of neonatal myocytes and ﬁbroblasts with (A) LPP (red); (B) a-actinin (green); and (C) combination of staining of LPP (red) and a-actinin (green),
myocyte (m). (D) Western blots of LPP and actin protein in myocytes and ﬁbroblasts. (E) LPP protein expression is two-fold higher in ﬁbroblasts than myocytes p < 0.05, n = 3.
Immunostaining of ﬁbroblasts with (F) LPP (green); (G) the focal adhesion protein ILK (red); (H) and combination staining of LPP (green) and ILK (red). White arrow shows the
nucleus. Immunostaining of ﬁbroblasts treated with 10 nM leptomycin B for 3 h to block nuclear export with (I) LPP (green); (J) the focal adhesion protein ILK (red); and
combination staining of LPP (green) and ILK (red).
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sue was stored in liquid nitrogen prior to being shipped to Reading.
We previously found that both hearts developed signiﬁcant hyper-
trophy with MI and AOB heart weights increasing by 28% and 47%
respectively compared with sham operated controls. The contrac-
tile function (left ventricular developed pressure) of the MI hearts
was signiﬁcantly reduced compared with controls. However, in
AOB hearts, both the left ventricular systolic pressure and end dia-stolic pressure were signiﬁcantly elevated compared with MI. This
suggests that the AOB hearts were subjected to greater hemody-
namic overload. We hypothesized that LPP expression would be
regulated by this additional mechanical load. The expression of
LPP was compared with actin because it has been suggested that
LPP expression is inﬂuenced by the actin cytoskeleton. Fig. 1D
and E show that LPP is signiﬁcantly increased following aortic con-
striction while total actin levels remained unchanged. Next we
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Fig. 3. (A) Western blots of LPP and vimentin protein in ﬁbroblasts treated with 10 lM cytochalasin D for 72 h to dissociate the actin cytoskeleton, alone and in combination
with 48 h mechanical stretch with 5% maximum strain at 1 Hz. (B) LPP protein expression decreased after 48 h with 5% mechanical stretch and dissociation of the actin
cytoskeleton with cytochalasin D (p < 0.05, n = 3). Immunostaining of ﬁbroblasts with LPP (green) (C) in untreated cells; (D) after inhibition of nuclear export by 10 nM
leptomycin B for 3 h; (E) after dissociation of the actin cytoskeleton by 10 lM cytochalasin D for 72 h; and (F) in response to co-treatment with 10 lM cytochalasin D for 72 h
and 10nM leptomycin B for the last 3 h. Immunostaining of ﬁbroblasts with actin (green) (G) in untreated cells; (H) after exposure to 5% mechanical stretch for 48 h; (I) in
response to dissociation of the actin cytoskeleton by 10 lM cytochalasin D for 72 h; and (J) co-treatment with 10 lM cytochalasin D for 72 h and 5%mechanical stretch for the
last 48 h.
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change (Fig. 1F and G).
3.2. LPP expression in cardiac cells
Using immunostaining of neonatal cardiac cells we wanted to
determine which cells in the heart expressed LPP. Fig. 2A shows
that LPP is expressed in both myocytes and non-myocytes. The
expression in non-myocytes appears to be higher, mostly associ-
ated with the actin cytoskeleton. In myocytes the expression ap-
pears more punctate suggesting a strong association with the
focal adhesions. We then cultured neonatal cardiac ﬁbroblasts sep-
arately from myocytes and quantiﬁed the expression of LPP in the
two cell types. Fig. 2D and E show that ﬁbroblasts express more
LPP than myocytes. For this reason, subsequent work will examine
the activity of LPP in neonatal cardiac ﬁbroblasts. Cultured ﬁbro-blasts were treated with 10 nM leptomycin B for 2 h and the cells
ﬁxed for immunochemistry. Fig. 2F–K show immunostaining for
LPP and integrin linked kinase in ﬁbroblasts following treatment
with leptomycin B. Leptomycin B blocks the CRM1 nuclear export
pathway and allows LPP to accumulate in the nuclear as a result of
its shuttling. The staining indicates that the LPP localizes to the fo-
cal adhesions and accumulates in the nucleus following inhibition
of the CRM1 nuclear export pathway.
3.3. LPP expression is dependent on mechanical stress and the actin
cytoskeleton
Previous work in smooth muscle shows that LPP may be mech-
anosensitive so we determined whether this might also be the case
in cardiac ﬁbroblasts. We chose ﬁbroblasts for these experiments
because the expression is higher than in cardiac myocytes. In these
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Fig. 4. (A) Western blots of LPP and actin protein in response to dissociation of the microtubules using 10 lM vinblastine for 26 h; alone and in combination with 10%
mechanical stretch for 2 h. (B) LPP protein expression is unchanged in response to dissociation of the microtubules and after 2 h 10% mechanical stretch. Immunostaining of
ﬁbroblasts with LPP (green) (C) in untreated cells; (D) after inhibition of nuclear export by 10 nM leptomycin B for 3 h; (E) after dissociation of the microtubules with 10 lM
vinblastine for 26 h; and (F) in response to co-treatment with 10 lM vinblastine for 26 h and 10 nM leptomycin B for the last 3 h. Immunostaining of ﬁbroblasts for tubulin
(green) (G) in untreated cells; (H) after exposure to 2 h mechanical stretch at 10% maximum strain at 1 Hz; (I) after dissociation of the microtubules with 10 lM vinblastine
for 26 h; and (J) in response to co-treatment with 10 lM vinblastine for 26 h and 10% mechanical stretch for the last 2 h.
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4000 with or without the presence of the actin cytoskeleton. The
actin cytoskeleton was dissociated using cytochalasin D. LPP
expression was then examined following the various treatments.
Fig. 3A and B show total LPP expression following mechanical cyc-
lic stretch with and without cytochalasin D. The data show that
both cyclic stretch and cytochalasin D signiﬁcantly decrease LPP
expression in cardiac ﬁbroblasts. The immunostained images for
these conditions are shown in Fig. 3C–J.
3.4. LPP expression is independent of the microtubule cytoskeleton
We tested to see whether dissociation of the microtubules
would have a similar effect as dissociating the actin cytoskeleton.In these experiments, cells were mechanically stretched using
the Flexcell 4000 with or without the presence of the microtubules.
LPP expression was then examined following the various treat-
ments. Fig. 4A and B show total LPP expression following 2 h of
mechanical cyclic stretch with and without vinblastine (16 h vin-
blastine treatment) which dissociates the microtubules. The data
show that neither short-term cyclic stretch nor the loss of microtu-
bules alter LPP expression in cardiac ﬁbroblasts. The immuno-
stained images for these conditions are shown in Fig. 4C–J.
3.5. Subcellular distribution of LPP is regulated by mechanical stress
Since LPP is a nucleocytoplasmic shuttling protein we wanted to
determine how its subcellular distribution was altered by different
AB
Fig. 5. (A) Western blots of LPP protein in the cytosolic, membrane, nucleus and cytoskeleton subcellular fractions in response to inhibition of nuclear export with 10 nM
leptomycin B for 3 h and dissociation of the actin cytoskeleton with 10 lM cytochalasin D for 26 h; both alone and in combination with 2 h 10% mechanical stretch. (B) LPP
distribution in ﬁbroblasts. Fibroblasts were fractionated into cytosol, membrane, nucleus and cytoskeleton subcellular portions using a detergent-based method. Treatment of
ﬁbroblasts with 10 nM leptomycin B for 3 h, alone and in combination with 2 h 10% mechanical stretch, leads to increased nuclear LPP. (C) LPP protein expression in the
membrane in response to leptomycin B, cytochalasin D and 10% mechanical stretch. LPP membrane localization declined in response to 2 h 10% mechanical stretch. (D) LPP
protein expression in the nucleus in response to leptomycin B, cytochalasin D and 10% mechanical stretch. LPP nuclear localization increased when nuclear export was
blocked by leptomycin B. (E) LPP protein expression in the cytosol in response to leptomycin B, cytochalasin D and 10% mechanical stretch. (F) LPP protein expression in the
cytoskeleton in response to leptomycin B, cytochalasin D and 10% mechanical stretch. LPP cytoskeletal localization increased when nuclear export was blocked by leptomycin
B, alone and in combination with 10% mechanical stretch. ⁄ Represents differences vs control where p < 0.05, n = 3 different cultures.
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into cytosol, membrane, nucleus and cytoskeletal portions for
Western blotting. Fig. 5A shows a Western blot of LPP protein in
the 4 fractions. Fig. 5B shows just under 40% of the protein is found
in the cytosolic fraction and around 30% in the membrane in con-
trol cells. The rest is distributed between the nucleus and cytoskel-
etal fractions. We then determined the effect of cyclic mechanical
stretch and cytochalasin D on LPP subcellular distribution. Lepto-
mycin B was used as a positive control to test the methodology
since the drug results in nuclear accumulation of LPP. Short term
cyclic stretch and leptomycin B result in decreased membrane
LPP (Fig. 5C). LPP levels were further reduced in all fractions fol-
lowing cytochalasin D treatment. In the non-cytochalasin D treat-
ment group leptomycin B treatment resulted in increased nuclear
LPP (Fig. 5D) consistent with the immunostaining in Fig. 2F and I.
However, cyclic stretch alone did not result in a change of nuclear
LPP. Fig. 5E shows that none of the treatments altered LPP expres-
sion in the cytosol, however leptomycin did signiﬁcantly increase
the protein amounts in the cytoskeleton (Fig. 5F). The increase fol-lowing leptomycin treatment was abolished by the presence of
cytochalasin D.
3.6. Nitric oxide regulates LPP expression in cardiac ﬁbroblasts
Previous work has shown that nitric oxide (NO) levels are in-
creased by mechanical stimuli [17] and inﬂuence gene expression
in response to stretch. As a result we determined whether the
changes in LPP gene expression might be inﬂuenced by NO produc-
tion. Cardiac ﬁbroblasts were stretched with or without the nitric
oxide synthase (NOS) inhibitor LNAME to remove any endogenous
NO production during mechanical stimulation. Cells were treated
with 5 mM LNAME for 48 h and stretched cyclically at 5% maxi-
mum strain. After this treatment, cells were lysed and processed
for Western blotting. The expression of LPP was measured along
with other major ﬁbroblast genes a-smooth muscle actin and
pro-collagen. LPP expression decreased following long-term cyclic
stretch which was rescued by LNAME treated (Fig. 6B). Cyclic
stretch also decreased the expression of pro-collagen (Fig. 6C)
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NO production did not rescue the loss of these two proteins follow-
ing mechanical stress.4. Discussion
Here, we show for the ﬁrst time that LPP, an adaptor and nucle-
ocytoplasmic shuttling protein is highly expressed within the myo-
cardium and is regulated by nitric oxide and mechanical stress.
These ﬁndings are in contrast to a previous report that suggested
that the protein was poorly expressed within the heart [4]. That
observation was probably because the expression in the heart
was compared directly with smooth muscle where the expression
of LPP is much higher. Our data here show that LPP expression is
down regulated in the adult heart and re-expressed following car-
diac hypertrophy induced by increased hemodynamic loading. LPP
protein may therefore provide a novel marker for heart failure in-
duced by hemodynamic overload since its expression only in-
creased following pressure overload induced by aortic banding
but not after myocardial infarction in rats. These ﬁndings strongly
suggest that LPP may play an important role in mechano-depen-
dent myocardial growth and adaptation.
The possible role of LPP as a mechanosensor in the myocardium
is highly plausible since the protein has been shown to be mecha-
nosensitive in smooth muscle cells. In smooth muscle cells LPP was
shown to be important for cytoskeletal organization and its expres-
sion was regulated by the mechanical environment [11]. This sug-
gests that LPP may provide a direct link between cytoskeletal
remodeling and mechanical overload. LPP was shown to interactwith ETV5 in endometrial carcinomas and together act as a sensor
of the extracellular environment [18]. The activities of the protein
in heart have not been previously investigated but its highly regu-
lated expression there suggests an important role in myocardial
function. At any given time, there is little LPP in the nucleus in car-
diac cells as seen by our immunochemistry or subcellular fractions.
However, blocking nuclear export with leptomyocin results in the
rapid nuclear accumulation of the protein in cardiac ﬁbroblasts
within a few minutes. This would suggest a highly regulated but
very short nuclear retention time, raising the possibility that the
LPP could also act as a nucleocytoplasmic courier for other signal-
ing proteins. This hypothesis is supported by the fact that LPP
interacts with another focal adhesion protein called LASP-1 which
has no nuclear localization signal of its own, but still localizes to
the nucleus [19]. Altered LPP expression in cardiac hypertrophy
along with changes in its subcellular distribution following stretch
suggest a possible role in mechanically-linked growth and gene
expression. The presence of LPP in the focal adhesions places it in
an area of force transmission between the cell membrane and
extracellular matrix.
It has been suggested that LPP may act as a co-activator allow-
ing co-localization of other proteins to promoter sites. This role is
supported by the fact that LPP binds and alters the activity of the
transcription factor PEA3 [20], however it does not directly regu-
late its activity. LPP has been shown to bind to a large variety of
molecules, facilitated by interactions with LIM and PDZ domains.
It interacts with a variety of upstream components of the ERK sig-
naling pathway, resulting in NF-jB activation and the concomitant
changes in gene expression [21]. This could allow LPP to provide a
link between the extracellular mechanical environment and cellu-
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Fig. 6. (A) Western blots of pro-collagen, LPP, a-smooth muscle actin and actin protein expression in response to inhibition of NO synthesis using 5 mM LNAME for 48 h,
alone and in combination with exposure to mechanical stretch for 48 h at 5% maximum strain at 1 Hz. (B) LPP protein expression in response to inhibition of NO synthesis
using 5 mM LNAME for 48 h; alone and in combination with mechanical stretch for 48 h at 5% maximum strain at 1 Hz. (C) Pro-collagen protein expression in response to
inhibition of NO synthesis using 5 mM LNAME for 48 h, alone and in combination with exposure to mechanical stretch for 48 h at 5% maximum strain at 1 Hz. (D) a-Smooth
muscle actin protein expression in response to inhibition of NO synthesis using 5 mM LNAME for 48 h, alone and in combination with mechanical stretch for 48 h at 5%
maximum strain at 1 Hz. ⁄ Represents differences vs control where p < 0.05, n = 3 cultures.
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ber of a family of LIM domain containing proteins that include zyx-
in and TRIP6. Knockdown of LPP may be compensated for by the
activity of TRIP6 and zyxin, which are also focal adhesion nucleo-
cytoplasmic shuttling proteins [3]. This functional redundancy is
supported by the fact that neither LPP nor zyxin knockout mice
have a discernible phenotype. However, knockdown of LPP did re-
sult in reduced alpha actinin and another binding partner palladin
[3]. Clearly, multiple knockouts are needed to determine the func-
tion of these potentially important proteins.
Our ﬁndings suggest that LPP expression is regulated by both
the mechanical environment and nitric oxide. Nitric oxide is up-
regulated in cardiac hypertrophy and failure as well as by mechan-
ical stimuli [17]. This complex interplay between nitric oxide and
mechanical cues could explain the difference in LPP expression be-
tween the aortic banded and myocardial infarct models of heart
failure. All forms of heart failure eventually lead to increased
mechanical stress but the hemodynamic data for these models
suggest a greater degree of preload and afterload in the AOBmodel.
Our data show that inhibition of NO production can rescue the
stretch-induced down-regulation of LPP, suggesting that the
stretch-induced down-regulation of LPP is NO dependent. NO has
been shown to modify focal adhesions where a signiﬁcant amount
of the protein resides [22]. NO can have a direct effect on Zn2+ con-
taining transcription factors by ejecting the cation from zinc ﬁn-
gers [23]. Mechanical stretch also increases NO production [17]
which could in turn lead to the degradation of LPP through the
mechanisms mentioned previously. This is consistent with our
ﬁnding that inhibition of NO production up-regulates the protein
expression. NO can facilitate post-translational regulation of gene
expression by directly affecting mRNA stability and translation
[24]. Finally, NO could have an indirect effect on LPP proteinexpression through its interaction with numerous signaling path-
ways [25].
In conclusion, we have shown that LPP is highly expressed and
regulated in the myocardium but its highest expression is in car-
diac ﬁbroblasts. The protein is down regulated in the adult heart
but re-expressed following cardiac hypertrophy induced by hemo-
dynamic overload. These ﬁndings suggest that the protein may
play a role in mechano-dependent growth and this link is regulated
through nitric oxide signaling. To determine additional roles of LPP,
it is likely that double or even triple knockouts would have to be
produced because of its functional overlap with zxyin and TRIP6.
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